Susannah Calhoun

Susannah Calhoun, PhD, is a highly experienced scientist specializing in translational biology, currently serving as Principal Scientist at Incendia Therapeutics since April 2022. Previously, Susannah held the position of Senior Scientist and Postdoctoral Fellow at Novartis Institutes for BioMedical Research, where significant contributions included studying the biology of inhibitory immune cell receptors in tumor microenvironments using advanced spatial genomics techniques. Susannah's academic background includes a PhD in Microbiology and Molecular Parasitology from Weill Cornell Graduate School of Medical Sciences, where research focused on genome stability and DNA repair mechanisms in Plasmodium falciparum. Prior roles include research positions at Weill Cornell Medicine, Regeneron Pharmaceuticals, Merck, and an internship with NASA Langley Research Center.